Tumor doxorubicin distribution for PLAD appeared to be polarized into two groups with one group (n=4) very similar to PLD and the other group (n=3) showing higher tumor doxorubicin levels than PLD (Figure 2A). This evidence concerns the gene GPLD1 and neoplasm.